Results from the Phase II WILLOW trial show that enpatoran achieved a statistically significant dose-response and clinically ...

Positive feedback was based on Phase III AQUILA trial results, which showed a significant clinical benefit with Darzalex Faspro in patients with high-risk smoldering multiple myeloma.

Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively ...

The film tells the story of a family impacted by the disease and shares the importance of checking to make sure that children are vaccinated against all strains.